Related Experiment Video
Updated: Aug 31, 2025

Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
COVID-19 in a mosaic trisomy 13 patient with polycystic kidney disease
Natalie K Ost1, Heather M Minchew2, Andrew Garcia3
1Children's Mercy Hospital, Kansas City, MO, USA.
Insights
This case study highlights severe COVID-19 in a young patient with mosaic trisomy 13 and kidney disease. It underscores the need for tailored management strategies for vulnerable pediatric populations.
Area of Science:
- Infectious Diseases
- Genetics
- Pediatrics
Background:
- Limited research exists on severe COVID-19 in younger patients, particularly those with chromosomal abnormalities.
- Existing management protocols are primarily designed for elderly populations, leaving gaps for pediatric cases.
Observation:
- A young patient with mosaic trisomy 13 and polycystic kidney disease presented with severe COVID-19.
- The patient experienced severe acute hypoxic respiratory failure and acute kidney injury.
Findings:
- The case demonstrates a severe COVID-19 presentation in a pediatric patient with complex underlying conditions.
- Maximal pharmacological support was administered to manage the critical illness.
Implications:
- This case contributes to understanding COVID-19 in patients with chromosomal abnormalities and significant comorbidities.
- Findings may inform the development of more specific clinical guidelines for managing severe COVID-19 in vulnerable pediatric groups.
Abstract:
Presentation, management, and outcomes of COVID-19 infections among younger patients is an area of medicine with deficits in research, likely due to the lower incidence of severe COVID-19 disease among the younger population. Management can be challenging, and clinicians often guide their decision-making based on the ever-changing protocols that are tailored mostly to the elderly population. Even more underrepresented in COVID-19 research are patients with chromosomal abnormalities and trisomy syndromes, as they appear less frequently, but have risk of increased morbidity and mortality due to underlying medical conditions. We describe a case of severe COVID-19 infection in a young patient with mosaic trisomy 13 and pre-existing polycystic kidney disease, who developed severe acute hypoxic respiratory failure and acute chronic kidney injury. The patient was provided maximal pharmacological support and her clinical course helps to shape the understanding of COVID-19 infections in the setting of chromosomal abnormalities and complex medical history.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Acute Kidney Injury IV: Diagnostic Studies and Prevention